Summary
Alexza Pharmaceuticals, Inc. (Alexza), formerly Alexza Molecular Delivery Corp., is a specialty pharmaceutical company. The company carries out the research and development and commercializes novel proprietary products used for the acute treatment of central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system. The product candidate's that the company offers includes ADASUVE (Staccato loxapine), AZ-104 (Staccato loxapine), AZ-003 (Staccato fentanyl), AZ-002 (Staccato alprazolam), AZ-007 (Staccato zaleplon) and Staccato nicotine (Preclinical). Alexza is headquartered at Mountain View in California, the US.
The company focus on developing and commercializing the innovative, cost- effective novel proprietary products based on its Staccato system, that address significant unmet medical needs in the treatment of acute and intermittent conditions. It also aims to maintain its existing partnerships and to enter new collaborative agreements to fuel its services. This is indicated by its partnership and collaboration agreement with Grupo Ferrer, for specific expertise to maximize the value of some product candidates. The company also plans to enter into strategic alliances with other pharmaceutical companies, to combine its Staccato system with their proprietary compounds.
Alexza Pharmaceuticals, Inc. (ALXA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Medical Equipment And Supply Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 4
Alexza Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 5
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 6
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 7
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 8
Alexza Pharmaceuticals, Inc., Medical Equipment, Deal Details 9
Equity Offering 9
Alexza Pharma Completes Private Placement Of Shares For $3 Million 9
Alexza Pharma Completes Private Placement Of Units For $16 Million 11
Alexza Pharma Completes Registered Direct Offering Of $18 Million 13
Alexza Pharma Announces Private Placement Of $25 Million 15
Alexza Pharma Completes Private Placement Of $1 Million 17
Alexza Pharma Completes Private Placement Of $19.7 Million 18
Alexza Pharma Completes Private Placement Of $10 Million 20
Alexza Pharma Completes Public Offering Of $70.73 Million 22
Alexza Pharmaceuticals, Inc. - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Nov 06, 2012: Alexza Pharma Reports Q3 2012 Results 27
May 10, 2012: Alexza Pharma Reports Revenue Of $1.9m In Q1 2012 28
Mar 12, 2012: Alexza Pharma Reports Revenue Of $1.9m In Q4 2011 29
Corporate Communications 30
Aug 01, 2012: Alexza Pharma Announces Management Promotions 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Tables
Alexza Pharmaceuticals, Inc., Medical Equipment, Key Facts, 2011 1
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 1
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 1
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 1
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 1
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 4
Alexza Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 5
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 6
Alexza Pharmaceuticals, Inc., Deals By Market, 2007 to YTD 2013 7
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 8
Alexza Pharma Completes Private Placement Of Shares For $3 Million 9
Alexza Pharma Completes Private Placement Of Units For $16 Million 11
Alexza Pharma Completes Registered Direct Offering Of $18 Million 13
Alexza Pharma Announces Private Placement Of $25 Million 15
Alexza Pharma Completes Private Placement Of $1 Million 17
Alexza Pharma Completes Private Placement Of $19.7 Million 18
Alexza Pharma Completes Private Placement Of $10 Million 20
Alexza Pharma Completes Public Offering Of $70.73 Million 22
Alexza Pharmaceuticals, Inc., Key Competitors 24
Alexza Pharmaceuticals, Inc., Key Employees 25
Alexza Pharmaceuticals, Inc., Subsidiaries 26
List of Figures
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013 1
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 4
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013 5
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 6
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals by Market, 2007 to YTD 2013 7